Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Long-Term Deferred Tax (2022 - 2023)

Envoy Medical's Long-Term Deferred Tax history spans 1 years, with the latest figure at $44.4 million for Q4 2022.

  • For Q4 2022, Long-Term Deferred Tax changed N/A year-over-year to $44.4 million; the TTM value through Dec 2022 reached $44.4 million, changed N/A, while the annual FY2022 figure was $44.4 million, N/A changed from the prior year.
  • Long-Term Deferred Tax for Q4 2022 was $44.4 million at Envoy Medical.
  • Across five years, Long-Term Deferred Tax topped out at $44.4 million in Q4 2022 and bottomed at $44.4 million in Q4 2022.